Binding of human beta 2-microglobulin to murine EL4 thymoma cells upregulates MHC class I heavy-chain epitopes, inhibits IL-2 secretion and induces resistance to killing by natural killer cells.

Research output: Contribution to journalJournal articleResearchpeer-review

A variety of murine tumor cell lines was studied for its binding of exogeneously added human beta 2-microglobulin (h beta 2m). Three T lymphomas and one IL-2-dependent T-cell line (HT-1) bound substantial amounts of h beta 2m, whereas P815 mastocytoma cells, an Abelson virus-infected pre-B cell line (ABLS-8), X63 B-lymphoma cells and YAC cells did not bind h beta 2m. In two of the T lymphomas, EL4 and BW5147, binding of h beta 2m led to an increase in major histocompatibility complex class I (MHC-I) heavy-chain epitope expression as measured by anti-H-2K/D antibody binding and FACS analysis. EL4 cells which had bound h beta 2m decreased their rate of constitutive IL-2 secretion and became resistant to activated natural killer (NK) cell killing. The present data suggest the binding of h beta 2m to mouse T cells leads to conformational changes of MHC-I heavy chains which influence both effector and target functions of the cell.
Original languageEnglish
JournalImmunology Letters
Volume39
Issue number2
Pages (from-to)195-202
Number of pages7
ISSN0165-2478
Publication statusPublished - 1994

Bibliographical note

Keywords: Animals; Cytotoxicity, Immunologic; Epitopes; Flow Cytometry; Histocompatibility Antigens Class I; Interleukin-2; Killer Cells, Natural; Lymphoma, T-Cell; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Tumor Cells, Cultured; Up-Regulation; beta 2-Microglobulin

ID: 8746641